In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alinea Pharmaceuticals Inc.

www.alineapharma.com

Latest From Alinea Pharmaceuticals Inc.

Start-Up Previews (12/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The Double-edged Sword of Diabetes Drug Development, features profiles of Alba Therapeutics, Alinea, DiaKine and Diabetica. Plus these Start-Ups Across Health Care: Actimis, Luminous Medical, NABsys and Pathfinder Therapeutics.

The Double-edged Sword of Diabetes Drug Development

Intense interest in new diabetes drugs gives start-ups many choices for technology development or in-licensing, but recent regulatory caution also increases risk.

BioPharmaceutical Regulation

Alinea Pharmaceuticals Inc.

Alinea Pharmaceuticals was founded recently around three in-licensed development programs, encompassing a Phase II-ready molecule to treat diabetic complications, a set of leads against a novel serum glucose-regulating target of significant interest to Big Pharma, and a research program around novel methods for lipid control.

BioPharmaceutical Research and Development Strategies

Selected Start-Ups (11/05)

In Vivo briefly summarizes the technologies of these recently founded companies: Alinea Pharmaceuticals, Neuronascent, Satori Pharmaceuticals, Stokes Bio, Tigris Pharmaceuticals and Triage Wireless.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register